According to the company, the AccuVax Vaccine Management System streamlines vaccine workflow, saves nursing time, minimizes vaccine waste, safeguards vaccine potency, and helps protect against medical errors.
Vaccines are one of the most significant public health successes. Yet, lapses in handling can render a vaccine ineffective and may leave people unprotected or needing revaccination, according to the Centers for Disease Control and Prevention.
Inventory losses due to power failure, improper storage and expired doses are common, and have created challenges for even the most advanced practices and health systems.
According to the company, AccuVax offers key advantages over conventional vaccine refrigeration and storage practices.
The system automates time-consuming storage, handling, and documentation tasks. It also dramatically simplifies compliance with CDC guidelines, as well as the requirements of the federally funded vaccine program.
AccuVax is the purpose-built vaccine supply management system that automates product control and integrity, minimises risks of incorrect vaccine delivery, and optimises office work flow so that providers can focus on care delivery.
It is an integrated solution that includes hardware, software, online access, software updates, training, optional integrations, technical support and maintenance.
TruMed Systems, a medical technology company developing innovative point-of-care supply management systems for healthcare professionals.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine